NoticiasCon ayuda de IA
Pharma Now Reports on Biologics Workshop 2025: A Global Convergence of Biopharma Excellence
Industry leaders gathered in Goa to discuss biosimilars, gene editing, and the future of biopharma.
Por Simantini Singh Deo
Redactor/a Senior
1 feb 2025Updated Jun 26, 2025 · 2 min de lectura
.webp&w=1920&q=75&dpl=dpl_DvHKTkTrxtw9jHK6MpkEndZCmmr3)
Reportaje con ayuda de IA
Reviewed by Simantini Singh Deo, Redactor/a Senior
Goa, February 2025 – Pharma Now is delighted to present an exclusive report on the Biologics Workshop 2025, a prestigious event organized by the Institute of Chemical Technology (ICT) at the picturesque Novotel Goa Resort and Spa. The event brought together some of the brightest minds in the biopharmaceutical industry, fostering insightful discussions, innovative ideas, and global collaborations.
A Perfect Blend of Knowledge and Ambiance
Set against the serene backdrop of Goa, the event offered the perfect environment for learning, networking, and collaboration. Novotel Goa served as an excellent venue, providing state-of-the-art facilities and a relaxing atmosphere, which complemented the intellectually stimulating sessions.Engaging Panel Discussions
The highlight of the event was the series of thought-provoking panel discussions. Experts delved into pressing topics such as:- The future of biosimilars and biologics development.
- Advancements in gene editing technologies like CRISPR.
- Innovations in bioprocessing and manufacturing technologies.
These sessions were highly interactive, sparking engaging debates and offering actionable insights. Attendees actively participated, asking questions and sharing their experiences, making the discussions both lively and informative.
Global Experts in the Spotlight
The workshop featured an impressive lineup of speakers, including:
- Dr. Rajesh S. Gokhale, former Secretary of the Department of Biotechnology, discussing India’s contributions to biologics.
- Prof. Roger Hajjar, a leader in cardiovascular gene therapy.
- Dr. Hari Pujar, an experienced professional in biopharma manufacturing and innovation, offering insights into advancing manufacturing efficiencies.
- Dr. Rahul Singhvi, a distinguished expert in biopharma and biotech startups, providing valuable perspectives on growth strategies.
These sessions inspired attendees with cutting-edge knowledge and a vision for the future of biopharma.
Networking and Collaboration
The workshop provided a unique platform for participants to connect with global experts, fostering partnerships and collaborations. The ambiance of Novotel Goa further encouraged meaningful conversations and exchanges, leaving participants with not just knowledge but also lasting professional relationships.
A Visionary Event
The Biologics Workshop 2025 set a benchmark for knowledge-sharing and industry collaboration, addressing critical challenges and exploring opportunities in the biologics sector. ICT’s exemplary organization of the event underscored its commitment to advancing the biopharma industry.
Pharma Now is proud to have been part of this transformative event and looks forward to continuing its journey of connecting the global pharma community with the latest insights and innovations.About Pharma Now
Pharma Now is a leading media platform dedicated to the pharmaceutical industry. Through our publications, digital platforms, and strategic event partnerships, we aim to drive innovation, knowledge-sharing, and global collaboration in the pharma and life sciences sectors.
TemasNews
Written by
Simantini Singh Deo
Redactor/a Senior
Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.
Más de Pharma News
Todos los artículos →
Noticias
Medicus Pharma presenta al FDA el protocolo combinado de fase 2b/3 para Teverelix
Vaibhavi M. · 29 sept 2026
Noticias
Fresenius Kabi recibe una carta de advertencia de la FDA tras fallos en la investigación del procesamiento aséptico en la planta de Melrose Park
Vaibhavi M. · 29 sept 2026
Noticias
Celmade recibe una carta de advertencia de la FDA por la venta de toxina botulínica inyectable no autorizada en EE. UU.
Vaibhavi M. · 29 sept 2026
Discussion